LT - Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
EN - Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07K 16/26 |
|
|
|
A61K 39/395 |
|
|
|
A61P 31/00 |
|
|
|
A61P 9/00 |
|
|
|
A61P 13/12 |
|
European patent
| (11) |
Number of the document |
2594587 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
12193118.2 |
|
Date of filing the European patent application |
2012-11-16 |
| (97) |
Date of publication of the European application |
2013-05-22 |
| (45) |
Date of publication and mention of the grant of the patent |
2014-05-21
|
| (46) |
Date of publication of the claims translation |
|
Priority applications
| (30) |
Number |
Date |
Country code |
|
11189450 |
2011-11-16
|
EP |
|
12160017 |
2012-03-16
|
EP |
Inventors
| (72) |
Bergmann, Andreas, DE
|
Grantee
| (73) |
AdrenoMed AG,
Neuendorfstrasse 15a, 16761 Hennigsdorf,
DE
|
Title
| (54) |
Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
| |
Anti-Adrenomedullin (ADM) antibody or anti-ADM antibody fragment or anti-ADM non-Ig protein scaffold for reducing the risk of mortality in a patient having a chronic or acute disease or acute condition |
